Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Screening and evaluation of approved drugs as inhibitors of main protease of SARS-CoV-2
Authors
Keywords
3CL-protease, Activity inhibition, Drug repurposing
Journal
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
Volume 164, Issue -, Pages 2622-2631
Publisher
Elsevier BV
Online
2020-08-24
DOI
10.1016/j.ijbiomac.2020.08.166
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Processing of the SARS-CoV pp1a/ab nsp7-10 region
- (2020) Boris Krichel et al. BIOCHEMICAL JOURNAL
- Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS‐CoV, MERS‐CoV, and 2019‐nCoV
- (2020) Jia Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Therapeutic options for the 2019 novel coronavirus (2019-nCoV)
- (2020) Guangdi Li et al. NATURE REVIEWS DRUG DISCOVERY
- Glecaprevir and Maraviroc are high-affinity inhibitors of SARS-CoV-2 main protease: Possible therapeutic implication in COVID-19
- (2020) Anas Shamsi et al. BIOSCIENCE REPORTS
- Teicoplanin: an alternative drug for the treatment of COVID-19?
- (2020) Sophie Alexandra Baron et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Endothelial cell infection and endotheliitis in COVID-19
- (2020) Zsuzsanna Varga et al. LANCET
- Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors
- (2020) Zhenming Jin et al. NATURE
- A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19
- (2020) Bin Cao et al. NEW ENGLAND JOURNAL OF MEDICINE
- Crystal structure of SARS-CoV-2 main protease provides a basis for design of improved α-ketoamide inhibitors
- (2020) Linlin Zhang et al. SCIENCE
- Susceptibility of ferrets, cats, dogs, and other domesticated animals to SARS–coronavirus 2
- (2020) Jianzhong Shi et al. SCIENCE
- Boceprevir, GC-376, and calpain inhibitors II, XII inhibit SARS-CoV-2 viral replication by targeting the viral main protease
- (2020) Chunlong Ma et al. CELL RESEARCH
- Thrombocytopenia is associated with severe coronavirus disease 2019 (COVID-19) infections: A meta-analysis
- (2020) Giuseppe Lippi et al. CLINICA CHIMICA ACTA
- Insights into SARS-CoV-2 genome, structure, evolution, pathogenesis and therapies: Structural genomics approach
- (2020) Ahmad Abu Turab Naqvi et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE
- Halogen Bond Interactions of Novel HIV-1 Protease Inhibitors (PI) (GRL-001-15 and GRL-003-15) with the Flap of Protease Are Critical for Their Potent Activity against Wild-Type HIV-1 and Multi-PI-Resistant Variants
- (2019) Shin-ichiro Hattori et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Chloroquine inhibits autophagic flux by decreasing autophagosome-lysosome fusion
- (2018) Mario Mauthe et al. Autophagy
- Pharmacodynamics of teicoplanin against MRSA
- (2017) V Ramos-Martín et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Glycopeptide Antibiotics Potently Inhibit Cathepsin L in the Late Endosome/Lysosome and Block the Entry of Ebola Virus, Middle East Respiratory Syndrome Coronavirus (MERS-CoV), and Severe Acute Respiratory Syndrome Coronavirus (SARS-CoV)
- (2016) Nan Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- SARS and MERS: recent insights into emerging coronaviruses
- (2016) Emmie de Wit et al. NATURE REVIEWS MICROBIOLOGY
- SARS-CoV 3CL protease cleaves its C-terminal autoprocessing site by novel subsite cooperativity
- (2016) Tomonari Muramatsu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Chalcones isolated fromAngelica keiskeiinhibit cysteine proteases of SARS-CoV
- (2015) Ji-Young Park et al. JOURNAL OF ENZYME INHIBITION AND MEDICINAL CHEMISTRY
- Intrinsic Tryptophan Fluorescence in the Detection and Analysis of Proteins: A Focus on Förster Resonance Energy Transfer Techniques
- (2014) Amar Ghisaidoobe et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Autoprocessing mechanism of severe acute respiratory syndrome coronavirus 3C-like protease (SARS-CoV 3CLpro) from its polyproteins
- (2013) Tomonari Muramatsu et al. FEBS Journal
- Dynamically-Driven Inactivation of the Catalytic Machinery of the SARS 3C-Like Protease by the N214A Mutation on the Extra Domain
- (2011) Jiahai Shi et al. PLoS Computational Biology
- Mutation of Glu-166 Blocks the Substrate-Induced Dimerization of SARS Coronavirus Main Protease
- (2010) Shu-Chun Cheng et al. BIOPHYSICAL JOURNAL
- Maturation Mechanism of Severe Acute Respiratory Syndrome (SARS) Coronavirus 3C-like Proteinase
- (2010) Chunmei Li et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Assessment of in vitro prophylactic and therapeutic efficacy of chloroquine against chikungunya virus in vero cells
- (2010) Mohsin Khan et al. JOURNAL OF MEDICAL VIROLOGY
- Sigma's Non-specific Protease Activity Assay - Casein as a Substrate
- (2008) Carrie Cupp-Enyard Jove-Journal of Visualized Experiments
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started